524663
BIBCL
Start SIP
Invest Now
Start SIP in BIBCL
Performance
- Low
- ₹19
- High
- ₹19
- 52 Week Low
- ₹17
- 52 Week High
- ₹29
- Open Price₹19
- Previous Close₹19
- Volume14,967
- 50 DMA₹19.25
- 100 DMA₹19.95
- 200 DMA₹21.22
Investment Returns
- Over 1 Month + 0.75%
- Over 3 Month -6.92%
- Over 6 Month -12.22%
- Over 1 Year -15.42%
Smart Investing Starts Here Start SIP with Bharat Immunological & Biologicals Corporation for Steady Growth!
Bharat Immunological & Biologicals Corporation Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -4.4
- PEG Ratio
- 0
- Market Cap Cr
- 81
- P/B Ratio
- 0.9
- Average True Range
- 1.13
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0
- RSI
- 48.07
- MFI
- 70.29
Bharat Immunological & Biologicals Corporation Financials
Bharat Immunological & Biologicals Corporation Technicals
EMA & SMA
Current Price
₹18.82
-0.12
(-0.63%)
- Bearish Moving Average 14
- Bullish Moving Average 2
- 20 Day
- ₹19.00
- 50 Day
- ₹19.25
- 100 Day
- ₹19.95
- 200 Day
- ₹21.22
Resistance and Support
18.87
- R3 19.73
- R2 19.46
- R1 19.14
- S1 18.55
- S2 18.28
- S3 17.96
Bharat Immunological & Biologicals Corporation Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-16 | General Purpose. | |
| 2024-03-08 | Others | General Purpose |
| 2023-10-31 | Quarterly Results | |
| 2023-04-24 | Audited Results | |
| 2023-02-09 | Quarterly Results |
Bharat Immunological & Biologicals Corporation F&O
About Bharat Immunological & Biologicals Corporation
- NSE Symbol
- BIBCL
- BSE Symbol
- 524663
- Managing Director
- Dr. Sanjay Kumar Mishra
- ISIN
- INE994B01014
Similar Stocks to Bharat Immunological & Biologicals Corporation
Bharat Immunological & Biologicals Corporation FAQs
Bharat Immunological & Biologicals Corporation share price is ₹18 As on 13 February, 2026 | 02:54
The Market Cap of Bharat Immunological & Biologicals Corporation is ₹81.3 Cr As on 13 February, 2026 | 02:54
The P/E ratio of Bharat Immunological & Biologicals Corporation is -4.4 As on 13 February, 2026 | 02:54
The PB ratio of Bharat Immunological & Biologicals Corporation is 0.9 As on 13 February, 2026 | 02:54
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.